China Gives Conditional Approval For Pfizer COVID Pill Paxlovid
15 feb 2022 ·
56 sec.
Iscriviti gratuitamente
Ascolta questo episodio e molti altri. Goditi i migliori podcast su Spreaker!
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
China says it has given conditional approval for Pfizer’s COVID-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease. Pfizer says...
mostra di più
China says it has given conditional approval for Pfizer’s COVID-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.
Pfizer says that preliminary studies show that Paxlovid does not target the ever-evolving spike protein the coronavirus uses to invade cells, meaning it should theoretically be more variant-proof.
China’s National Medical Products Administration says further research on the drug needed to be undertaken and submitted to the regulator.
Beijing has not yet approved any foreign-made coronavirus vaccines.
mostra meno
Pfizer says that preliminary studies show that Paxlovid does not target the ever-evolving spike protein the coronavirus uses to invade cells, meaning it should theoretically be more variant-proof.
China’s National Medical Products Administration says further research on the drug needed to be undertaken and submitted to the regulator.
Beijing has not yet approved any foreign-made coronavirus vaccines.
Informazioni
| Autore | Africa Business Radio |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
